ELEVECTA™ producer cell line
For stable, inducible adeno-associated virus (AAV) production.
ELEVECTA™ producer cell line
For stable, inducible adeno-associated virus (AAV) production.
Overview
- Simplified manufacturing process: Replace multi-step transfection with single-step production by adding an induction agent.
- Easy scalability: Scale up seamlessly to achieve large quantities of AAV material.
- Enhanced reproducibility: Benefit from a monoclonal cell line from which AAV is produced in an identical manner, enabling consistency from batch to batch.
- Reduced cost of goods: Skip the need for transfection reagent and any plasmid DNA, which are the most expensive raw materials in classical AAV transient transfection.
With Rep, Helper, Cap, and the gene of interest (GOI) stably integrated into the host cell’s genome, there is no need for plasmid transfection, no need of helper virus. Just induce and produce.
Watch the video or contact us at ELEVECTA@cytiva.com to speak directly to our specialists.
The ELEVECTA™ producer cell line is part of the ELEVECTA™ cell line porftolio. This portfolio combines innovative design and deep expertise to deliver transient, packaging, and producer options that provide high quality and the flexibility to transition as needs evolve. Interconnected through their common parental cell line, the three options create a complete cell line portfolio, supporting regulatory and quality uniformity.